Next-Generation JAK Inhibitors Signal the Future of Myelofibrosis Treatment Advances

Next-Generation JAK Inhibitors Signal the Future of Myelofibrosis Treatment Advances

0
Newer-generation JAK inhibitors are increasingly adept at controlling symptoms in patients with myelofibrosis and may recapture treatment response in patients who have progressed on...
Hoth Therapeutics' Wholly Owned Subsidiary Merveille.ai, Advances AI-Driven Discovery for Obesity Treatment

Hoth Therapeutics’ Wholly Owned Subsidiary Merveille.ai, Advances AI-Driven Discovery for Obesity...

0
Merveille.ai Files Patent for Obesity Treatment, Begins Preparatory Steps for Clinical Trials, Joins Nvidia Developer Program NEW YORK, March 27, 2024 /PRNewswire/ -- Hoth Therapeutics,...
Breakthrough discovery points to potential treatment for rare neurodegenerative disease

Breakthrough discovery points to potential treatment for rare neurodegenerative disease

0
Imagine being middle-aged and starting to feel that you are off balance...
Marshall Health Network offers breakthrough minimally-invasive treatment for patients with heart valve leakage

Marshall Health Network offers breakthrough minimally-invasive treatment for patients with heart...

0
The MitraClip™ procedure is now available at Marshall Health Network to treat individuals suffering from mitral valve regurgitation. The FDA-approved, minimally-invasive procedure addresses valve...
Denovo Biopharma Announces a Major Breakthrough in Treatment-Resistant Depression with Precision Medicine

Denovo Biopharma Announces a Major Breakthrough in Treatment-Resistant Depression with Precision...

0
ENLIGHTEN, a genetic biomarker–guided global late–stage clinical trial of DB104 (liafensine) for treatment–resistant depression, successfully met all major study endpointsSAN DIEGO, April 3, 2024...
Fitusiran and the Evolving Landscape

Fitusiran and the Evolving Landscape

0
This is a video synopsis/summary of an Insights featuring Steven W. Pipe, MD.Pipe delves into the emerging therapy, fitusiran, offering a novel approach to...
Investigational mRNA Vaccine Induced Persistent Immune Response in Phase 1 Trial of Patients With Pancreatic Cancer

Investigational mRNA Vaccine Induced Persistent Immune Response in Phase 1 Trial...

0
An experimental approach to treating pancreatic cancer with the messenger RNA (mRNA)-based therapeutic cancer vaccine candidate autogene cevumeran continues to show potential to stimulate...
FDA Grants Breakthrough Therapy Designation to Sunvozertinib for the First-Line Treatment of Patients with advanced Non-Small Cell Lung Cancer Harboring EGFR Exon 20 Insertion Mutations

FDA Grants Breakthrough Therapy Designation to Sunvozertinib for the First-Line Treatment...

0
SHANGHAI, April 7, 2024 /PRNewswire/ -- Dizal (688192.SH) today announced that the U.S. Food and Drug Administration ("FDA") has granted Breakthrough Therapy Designation (BTD)...
Dropper Research Stock - Large hi res

scientists present leading edge research at AACR

0
City of Hope® researchers will present more than 70 abstracts and sessions on innovative clinical trial results, breakthrough diagnostic techniques and advances in treatment...

Recent Posts